Bifidobacterium longum subsp. infantis BI221 (LMG P-29639)

Overview

Bifidobacterium longum subsp. infantis BI221 (LMG P-29639), developed by SynBalance.
Gastrointestinal Health • Immune prevention

Scientific reference(s)

Additional info

Therapeutical area(s)

Immune system

Functionality

Antioxidant · Immune stimulation

Age/Gender

Adults

Search strain on Pubmed

Bifidobacterium longum subsp. infantis BI221 (LMG P-29639) is available at

SynBalance SRL

Probiotics, LBPs, prebiotics & postbiotics + Production & Manufacturing

Probiotic blends with Bifidobacterium longum subsp. infantis BI221 (LMG P-29639)

Wellderly

MicrobiomeHUB is a space that brings together the companies of the microbiome industry

Brought to you by Clorofilla Scientific Publishing

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomeHUB’s Privacy Policy